BRITTANY TOWNSEND: Open Payments
NPI 1326794322 · ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 13 payments from 5 companies in 2025. Trend: 2023 $23 · 2024 $522 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 3 | $196 |
| Astellas Pharma US Inc | 3 | $82 |
| Sumitomo Pharma America, Inc. | 3 | $74 |
| Sage Therapeutics, LLC | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: SLYND, Veozah, ZURZUVAE, GEMTESA, MYFEMBREE, Mirena.
Industry payments across MA — which companies pay providers there.
